These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 30088174)

  • 1. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
    Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
    Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
    Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
    Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling.
    Ke M; Chong CM; Zeng H; Huang M; Huang Z; Zhang K; Cen X; Lu JH; Yao X; Qin D; Su H
    Cell Death Dis; 2020 Feb; 11(2):130. PubMed ID: 32071291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway.
    Chiu CC; Yeh TH; Lu CS; Huang YC; Cheng YC; Huang YZ; Weng YH; Liu YC; Lai SC; Chen YL; Chen YJ; Chen CL; Chen HY; Lin YW; Wang HL
    Oncotarget; 2017 Oct; 8(45):79046-79060. PubMed ID: 29108286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Miki Y; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2017 Apr; 645():40-45. PubMed ID: 28213071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease-associated
    Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
    Chu YT; Lin HY; Chen PL; Lin CH
    BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways.
    Sánchez E; Azcona LJ; Paisán-Ruiz C
    Mol Neurobiol; 2018 Aug; 55(8):6734-6754. PubMed ID: 29344929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations.
    Chiu CC; Wang HL; Weng YH; Chen RS; Chen CM; Yeh TH; Lu CS; Chen YJ; Liu YC; Huang YZ; Chang KH
    Stem Cell Res; 2019 Oct; 40():101552. PubMed ID: 31493761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction.
    Sumi-Akamaru H; Beck G; Shinzawa K; Kato S; Riku Y; Yoshida M; Fujimura H; Tsujimoto Y; Sakoda S; Mochizuki H
    Acta Neuropathol Commun; 2016 Mar; 4():27. PubMed ID: 27030050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
    Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
    Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease.
    Zhou Q; Yen A; Rymarczyk G; Asai H; Trengrove C; Aziz N; Kirber MT; Mostoslavsky G; Ikezu T; Wolozin B; Bolotina VM
    Nat Commun; 2016 Jan; 7():10332. PubMed ID: 26755131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes.
    Zhang W; Zhou M; Lu W; Gong J; Gao F; Li Y; Xu X; Lin Y; Zhang X; Ding L; Zhang Z; Li G; Chen X; Sun X; Zhu X; Xu P; Zhang Y
    Theranostics; 2020; 10(7):3000-3021. PubMed ID: 32194851
    [No Abstract]   [Full Text] [Related]  

  • 15. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
    Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
    Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
    Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
    Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.
    Chiu CC; Weng YH; Huang YZ; Chen RS; Liu YC; Yeh TH; Lu CS; Lin YW; Chen YJ; Hsu CC; Chiu CH; Wang YT; Chen WS; Liu SY; Wang HL
    Cell Death Dis; 2020 Nov; 11(11):1018. PubMed ID: 33257649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model.
    Weng YH; Chen CY; Lin KJ; Chen YL; Yeh TH; Hsiao IT; Chen IJ; Lu CS; Wang HL
    Exp Neurol; 2016 Jan; 275 Pt 1():104-15. PubMed ID: 26363496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort.
    Shi CH; Tang BS; Wang L; Lv ZY; Wang J; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Guo JF
    Neurology; 2011 Jul; 77(1):75-81. PubMed ID: 21700586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.